190 related articles for article (PubMed ID: 30333087)
21. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
22. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Mamounas EP; Bandos H; Lembersky BC; Jeong JH; Geyer CE; Rastogi P; Fehrenbacher L; Graham ML; Chia SK; Brufsky AM; Walshe JM; Soori GS; Dakhil SR; Seay TE; Wade JL; McCarron EC; Paik S; Swain SM; Wickerham DL; Wolmark N
Lancet Oncol; 2019 Jan; 20(1):88-99. PubMed ID: 30509771
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant aromatase inhibitor therapy in early breast cancer: what factors lead patients to discontinue treatment?
Moscetti L; Agnese Fabbri M; Sperduti I; Fabrizio N; Frittelli P; Massari A; Pompei L; D'Auria G; Pofi E; Ruggeri EM
Tumori; 2015; 101(5):469-73. PubMed ID: 26108239
[TBL] [Abstract][Full Text] [Related]
24. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
J Geriatr Oncol; 2014 Apr; 5(2):179-84. PubMed ID: 24495700
[TBL] [Abstract][Full Text] [Related]
25. The G8 screening tool detects relevant geriatric impairments and predicts survival in elderly patients with a haematological malignancy.
Hamaker ME; Mitrovic M; Stauder R
Ann Hematol; 2014 Jun; 93(6):1031-40. PubMed ID: 24488257
[TBL] [Abstract][Full Text] [Related]
26. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis.
Amir E; Seruga B; Niraula S; Carlsson L; Ocaña A
J Natl Cancer Inst; 2011 Sep; 103(17):1299-309. PubMed ID: 21743022
[TBL] [Abstract][Full Text] [Related]
27. Value of geriatric screening and assessment in predicting postoperative complications in patients older than 70 years undergoing surgery for colorectal cancer.
Fagard K; Casaer J; Wolthuis A; Flamaing J; Milisen K; Lobelle JP; Wildiers H; Kenis C
J Geriatr Oncol; 2017 Sep; 8(5):320-327. PubMed ID: 28781062
[TBL] [Abstract][Full Text] [Related]
28. [Aromatase inhibitors and arthralgia].
Nagykálnai T; Landherr L; Mészáros E
Magy Onkol; 2011 Mar; 55(1):32-9. PubMed ID: 21617789
[TBL] [Abstract][Full Text] [Related]
29. Validation of the G8 screening tool in older patients with cancer considered for surgical treatment.
Bruijnen CP; Heijmer A; van Harten-Krouwel DG; van den Bos F; de Bree R; Witteveen PO; Emmelot-Vonk MH
J Geriatr Oncol; 2021 Jun; 12(5):793-798. PubMed ID: 33172806
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
De Placido S; Gallo C; De Laurentiis M; Bisagni G; Arpino G; Sarobba MG; Riccardi F; Russo A; Del Mastro L; Cogoni AA; Cognetti F; Gori S; Foglietta J; Frassoldati A; Amoroso D; Laudadio L; Moscetti L; Montemurro F; Verusio C; Bernardo A; Lorusso V; Gravina A; Moretti G; Lauria R; Lai A; Mocerino C; Rizzo S; Nuzzo F; Carlini P; Perrone F;
Lancet Oncol; 2018 Apr; 19(4):474-485. PubMed ID: 29482983
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
Schulkes KJG; Souwer ETD; van Elden LJR; Codrington H; van der Sar-van der Brugge S; Lammers JJ; Portielje JEA; van den Bos F; Hamaker ME
Clin Lung Cancer; 2017 Nov; 18(6):660-666.e1. PubMed ID: 28320638
[TBL] [Abstract][Full Text] [Related]
32. Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor.
Kuria IM; Petekkaya I; Hasanov E; Babacan T; Dizdar O; Altundag K
J BUON; 2012; 17(4):798-9. PubMed ID: 23335547
[No Abstract] [Full Text] [Related]
33. Current opinion of aromatase inhibitor-induced arthralgia in breast cancer in the UK.
Din OS; Dodwell D; Winter MC; Mori S; Coleman RE
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):674-80. PubMed ID: 21788122
[TBL] [Abstract][Full Text] [Related]
34. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.
Dent SF; Gaspo R; Kissner M; Pritchard KI
Breast Cancer Res Treat; 2011 Apr; 126(2):295-310. PubMed ID: 21249443
[TBL] [Abstract][Full Text] [Related]
35. Validity and reliability of the G8 screening test in older non-cancer patients.
Cavusoglu C; Deniz O; Tuna Dogrul R; Ileri I; Yildirim F; Caliskan H; Ozsurekci C; Coteli S; Kizilarslanoglu MC; Goker B
Eur Geriatr Med; 2021 Apr; 12(2):397-404. PubMed ID: 33000425
[TBL] [Abstract][Full Text] [Related]
36. Improving tolerance of AIs: predicting risk and uncovering mechanisms of musculoskeletal toxicity.
Gold JM; Burstein HJ
Oncology (Williston Park); 2008 Nov; 22(12):1416, 1424. PubMed ID: 19322949
[No Abstract] [Full Text] [Related]
37. The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.
Chan WL; Ma T; Cheung KL; Choi H; Wong J; Lam KO; Yuen KK; Luk MY; Kwong D
J Geriatr Oncol; 2021 May; 12(4):557-562. PubMed ID: 33127385
[TBL] [Abstract][Full Text] [Related]
38. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
[TBL] [Abstract][Full Text] [Related]
39. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
Winer EP; Hudis C; Burstein HJ; Wolff AC; Pritchard KI; Ingle JN; Chlebowski RT; Gelber R; Edge SB; Gralow J; Cobleigh MA; Mamounas EP; Goldstein LJ; Whelan TJ; Powles TJ; Bryant J; Perkins C; Perotti J; Braun S; Langer AS; Browman GP; Somerfield MR
J Clin Oncol; 2005 Jan; 23(3):619-29. PubMed ID: 15545664
[TBL] [Abstract][Full Text] [Related]
40. Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
Presant CA; Bosserman L; Young T; Vakil M; Horns R; Upadhyaya G; Ebrahimi B; Yeon C; Howard F
Clin Breast Cancer; 2007 Oct; 7(10):775-8. PubMed ID: 18021478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
